Sort
16,300 grants matching “fatty liver disease”
Mechanism of GDNF regulation of Hepatic Steatosis
$0Shanthi K Srinivasan · Veterans Health Administration · I01 · FY2018 · VA
Study the role of oxysterol sulfates in NAFLD development
$0Shunlin Ren · Va Veterans Administration Hospital · I01 · FY2019 · VA
Cholesteryl ester transfer protein, a novel mediator of insulin sensitivity
$0John Micheal Stafford · Veterans Health Administration · I01 · FY2016 · VA
Cell-free DNA is a driver of non-alcoholic steatohepatitis via TLR9 activation
$0Wajahat Zafar Mehal · Va Connecticut Healthcare System · I01 · FY2017 · VA
Regulation of Carbohydrate Metabolism and Lipogenesis
$0Kosaku Uyeda · Va North Texas Health Care System · I01 · FY2016 · VA
BCCMA: Targeting Gut-Microbiome in Veterans Deployment related Gastrointestinal and Liver diseases; CMA5- Functional metagenomics in GWI-related gut dysfunction
$0Nasia Safdar · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2023 · VA
Cellular Mechanisms for Increased Gluconeogenesis in Type 2 Diabetes
$0Varman T Samuel · Va Connecticut Healthcare System · I01 · FY2012 · VA
Functional characters of non-coding RNAs in alcoholic liver injury
$0Fanyin Meng · Olin Teague Veterans Center · I01 · FY2012 · VA
Roles of Sphingolipids in the Pathophysiology of Obesity and Diabetes
$0Lauren Ashley Cowart · Va Veterans Administration Hospital · I01 · FY2019 · VA
Luminal Factors Affecting Duodenal Protection and Chemosensing
$0Jonathan D. Kaunitz · Va Greater Los Angeles Healthcare System · I01 · FY2019 · VA
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
$0William Irving Sivitz · Iowa City Va Medical Center · I01 · FY2015 · VA
Hormonal control of NASH development and progression
$0Rhonda D. Kineman · Jesse Brown Va Medical Center · I01 · FY2023 · VA
Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis
$0David E Kaplan · Philadelphia Va Medical Center · I01 · FY2022 · VA
BLR&D Research Career Scientist Award Application
$0Nicholas J Webster · Va San Diego Healthcare System · IK6 · FY2022 · VA
Sex hormones and HCV-related liver disease progression
$0Donna Lorraine White · Michael E Debakey Va Medical Center · I01 · FY2019 · VA
Promoting metabolic health through the reduction of dietary branched chain amino acids
$0Dudley William Lamming · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2022 · VA
Genetics of Cardiometabolic Diseases in the VA Population
$0Philip S Tsao · Veterans Admin Palo Alto Health Care Sys · I01 · FY2020 · VA
Circulating Biomarkers for the Detection of Human Liver Diseases
$0Courtney Wayne Houchen · Oklahoma City Va Medical Center · I01 · FY2020 · VA
PREVALENCE AND PREDICTORS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN VETERANS
$0Hashem B El-Serag · Michael E Debakey Va Medical Center · I01 · FY2020 · VA
Cell-free DNA is a driver of non-alcoholic steatohepatitis via TLR9 activation
$0Wajahat Zafar Mehal · Va Connecticut Healthcare System · I01 · FY2020 · VA
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
$0Hidekazu Tsukamoto · Va Greater Los Angeles Healthcare System · I01 · FY2020 · VA
CD47 as a therapeutic target for obesity
$0Shuxia Wang · Va Medical Center - Lexington, Ky · I01 · FY2020 · VA
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease
$0Huiping Rose Zhou · Va Veterans Administration Hospital · I01 · FY2020 · VA
Impact of Stress on Alcoholic Gut Injury
$0Radhakrishna Rao · Memphis Va Medical Center · I01 · FY2020 · VA
Catestatin improves glucose homeostasis and insulin sensitivity in diet-induced obese mice
$0Sushil K Mahata · Va San Diego Healthcare System · I01 · FY2020 · VA